Senior Director, Corporate Affairs, Communication and Policy Advocacy, Midsized Markets

Das ist der Job

The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. /ph3The Opportunity: /h3pThe Senior Director, Corporate Affairs will lead the development and execution of oncology-focused Corporate Affairs strategies in the Midsized Markets that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers.

The strategy should also be aligned with regional and global Corporate Affairs strategies. /ph3Key Responsibilities: /h3h3Media Relations /h3ulliActs as Midsized Markets spokesperson, directing enquiries to internal experts as needed. /liliDrives proactive media content and strategy around trial results, regulatory milestones, and major oncology congresses (ASCO, ESMO). /liliBuilds and maintains trusted relationships with top-tier Midsized Marketsand trade media, ensuring accurate representation of company positions and achievements. /liliMonitors media coverage and sentiment, flagging emerging narratives before they require a crisis response. /liliEnsures consistent messaging across earned, owned, and shared channels, and aligns spokesperson strategy and media plans with global priorities. /li /ulh3Corporate Reputation Management and Corporate Public Affairs /h3ulliOwns the country-level corporate reputation strategy for (COUNTRY), ensuring consistency with the global corporate narrative and brand. /liliMonitors reputation indicators and stakeholder sentiment, giving leadership early warning of emerging risks and opportunities. /liliLeads local crisis and issues management, protecting and enhancing the company's reputation during sensitive events. /liliBuilds executive visibility and thought leadership within the local business, healthcare, and policy community, positioning leaders as trusted voices on oncology innovation. /liliIn partnership with the local Value, Market Access and Pricing team, pursues corporate Public Affairs activities, including engagement with government and stakeholder institutions in Midsized Markets on broader company issues. /liliMaps and monitors the evolving policy environment in Midsized Markets including government, institutions, and regulatory bodies, flagging risks and opportunities to the business. /li /ulh3Internal Communication /h3ulliPartners with GMs, HR, and corporate functions to build a culture of transparency and pride in the company's oncology impact. /liliDesigns engagement strategies that build genuine commitment and translate strategy into clear priorities employees can act on. /liliAligns internal messaging with external priorities, cascading Midsized Markets policy and access milestones through engaging channels. /li /ulh3Product and Disease Area Communications /h3ulliLeads oncology communications strategy in Midsized Markets across disease awareness, launch, and lifecycle, including congress activity (ASCO, ESMO) that translates clinical data for HCP and media audiences, where and how permitted under local regulatory requirements. /liliCreates disease-awareness content for patients and caregivers, and partners with Medical Affairs to translate clinical data into HCP-facing communications. /liliEnsures communications comply with European promotional codes (EFPIA) and local regulations, maintaining clear promotional/non-promotional distinction and ethical standards. /li /ulh3Capability Building (Tech and AI) and Regional Alignment /h3ulliBuilds team fluency in AI-enabled tools for audience insight, message drafting, and real-time measurement and sets clear standards for responsible, compliant use. /liliDevelops best-practice toolkits, guidance, and training that build local advocacy and policy capacity, including AI and digital literacy. /liliTreats digital and AI-enabled engagement as core, not optional, to contemporary corporate affairs communications. /liliFosters cross-country learning and alignment on both policy initiatives and emerging tools and practice. /liliPartners with Region and Global to align Midsized Markets communications with the global narrative, feeding in policy insights, advocacy trends, and oncology milestones. /li /ulh3Required Skills, Experience and Education: /h3ulliDegree in Law, Communications, Political Science, Public Health, Life Sciences, or a related field. /liliExcellent leadership, influence, and team mindset. /liliStrong ability to develop and deliver impactful Communications and Public Affairs campaigns. /liliExcellent interpersonal, verbal, and written communication skills, including storytelling and policy translation for lay audiences. /liliSkilled in managing complex stakeholder environments and partnerships. /liliMinimum 10 years in Communications and Public Affairs in oncology. /liliStrong digital communications skills, with experience running campaigns and stakeholder engagement across web, social, and other digital channels. /liliHands-on fluency with generative AI tools for communications workflows (drafting, monitoring, sentiment analysis), with an understanding of responsible use, disclosure, and governance in a regulated industry. /liliDeep understanding of the European healthcare policy and oncology landscape. /liliProven track record of engaging with patient organizations, industry associations, and policymakers to deliver tangible policy and access outcomes. /liliExperience launching new oncology medicines and shaping policy to enable faster patient access. /liliFamiliarity with reimbursement, HTA processes, and access barriers in oncology. /liliTravel: Approximately 50% of time. /li /ulh3Preferred Skills: /h3ulliComprehensive understanding of the Midsized Marketshealthcare system, reimbursement landscape, regulatory frameworks, and policy-making processes. /liliProven track record of successfully influencing healthcare policy and stakeholder perspectives in competitive markets. /liliStrong strategic and analytical skills with ability to translate vision into actionable plans and navigate complex healthcare policy challenges. /liliSuccessful experience in cross-functional collaboration within matrix organizations and fast-paced entrepreneurial environments. /liliFluency in English, German, French, and/or Dutch is considered advantageous. /liliProficiency with MS Office and common business applications. /li /ulpRevolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone.

All legitimate communication from Revolution Medicines will come from an official b@revmed.com /b email address. /ppIf you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to so we can share these impersonations with our IT team for tracking and awareness. /p /p ppRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

These Corporate Affairs strategies bring together media relations, corporate public affairs, product communications, corporate reputation management and internal communications. /ppThis is an intentionally broad remit, spanning a wide range of disciplines. We are realistic that priorities will need to be set and will evolve over time.

We are seeking a versatile leader who approaches this breadth as an opportunity and who understands that the scope of the role reflects the scale of our ambition as a growing business. /ppReporting to the VP, Corporate Affairs, Europe with a strong dotted line to the General Manager, Midsized Markets, this role ensures that the Corporate Affairs strategy is primarily supporting local priorities and market requirements.

We will only collect, process and use any personal data that you provide to us in accordance with ourCCPA NoticeandPrivacy Policy.

For additional information, please contact /pp#LI-Hybrid #LI-LO1 /ppWe are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines.

These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message. /ppPlease note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.